Association between soluble immune mediators and outcomes in patients with unresectable stage III non-small cell lung cancer treated with concurrent chemoradiotherapy followed by durvalumab - Tokito, Takaaki; Azuma, Koichi; Murotani, Kenta; Matsuo, Norikazu; Matama, Goushi; Murata, Daiki; Sasada, Tetsuro; Hoshino, Tomoaki (Translational Lung Cancer Research, 2025)